Cisplatin and gemcitabine plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: a double-blind, randomized phase 2 trial.
Affiliation
Medical Oncology, University of Manchester/The Christie NHS Foundation Trust, ManchesterIssue Date
2016-10-01
Metadata
Show full item recordCitation
Cisplatin and gemcitabine plus ramucirumab or merestinib or placebo in first-line treatment for advanced or metastatic biliary tract cancer: a double-blind, randomized phase 2 trial. 2016, 27(suppl_6):712TiP Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw371.104Additional Links
https://academic.oup.com/annonc/article/2799361/CisplatinType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw371.104